Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANGELA M PARKER

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1285738427
CMS profile
10548326
Location
HORSEHEADS, NY

General Payments · PY2021–2024

$1,114.86

  • Reported across 54 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$246.63

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $246.63 16

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $148.10 11
Acerta Pharma LLC $35.95 2
Takeda Pharmaceuticals U.S.A., Inc. $22.47 1
Amgen Inc. $21.86 1
CSL Behring $18.25 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $454.09 15
PY2022 $33.13 2
PY2023 $381.01 21
PY2024 $246.63 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $21.86 03/28/2024 Food and Beverage Undisputed 01/23/2026 1115994737 CMS
AstraZeneca Pharmaceuticals LP $18.64 03/14/2024 Food and Beverage Undisputed 01/23/2026 1104395339 CMS
AstraZeneca Pharmaceuticals LP $17.31 06/19/2024 Food and Beverage Undisputed 01/23/2026 1105676915 CMS
CSL Behring $18.25 01/18/2024 Food and Beverage Undisputed 01/23/2026 1134622281 CMS
GlaxoSmithKline, LLC. $26.52 02/29/2024 Food and Beverage Undisputed 01/23/2026 1116400538 CMS
GlaxoSmithKline, LLC. $8.83 03/04/2024 Food and Beverage Undisputed 01/23/2026 1116693843 CMS
GlaxoSmithKline, LLC. $6.23 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116513745 CMS
GlaxoSmithKline, LLC. $4.46 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116648325 CMS
GlaxoSmithKline, LLC. $4.97 06/18/2024 Food and Beverage Undisputed 01/23/2026 1116273134 CMS
GlaxoSmithKline, LLC. $16.99 07/24/2024 Food and Beverage Undisputed 01/23/2026 1116557143 CMS
GlaxoSmithKline, LLC. $15.60 08/03/2024 Food and Beverage Undisputed 01/23/2026 1116239627 CMS
GlaxoSmithKline, LLC. $7.72 08/19/2024 Food and Beverage Undisputed 01/23/2026 1116543048 CMS
GlaxoSmithKline, LLC. $25.77 10/10/2024 Food and Beverage Undisputed 01/23/2026 1115874335 CMS
GlaxoSmithKline, LLC. $24.20 11/04/2024 Food and Beverage Undisputed 01/23/2026 1116682807 CMS
GlaxoSmithKline, LLC. $6.81 12/16/2024 Food and Beverage Undisputed 01/23/2026 1115884814 CMS
Takeda Pharmaceuticals U.S.A., Inc. $22.47 01/04/2024 Food and Beverage Undisputed 01/23/2026 1137804677 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.